A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

March 31, 2006

Conditions

Glioblastoma

Interventions

DRUG

Gefitinib

Trial Locations (3)

Research Site, Linköping

Research Site, Stockholm

Research Site, Umeå